Kidney cancer: open trials in China

117 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07087158
A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
Trial Treatment · Phase 2 · Imbioray (Hangzhou) Biomedicine Co., Ltd.
The Cancer Hospital of Fudan University, Shanghai
Registry updated 2026-11-05
NCT07909265
Prospective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
Trial Treatment · Phase 2 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Registry updated 2026-11-02
NCT07841756
Federated Learning in Renal Tumor Model
Research · First Affiliated Hospital of Guangxi Medical University
Guigang People's Hospital, Guigang · Guilin People's Hospital, Guilin · Liuzhou People's Hospital, Liuzhou · The First Affiliated Hospital of Guangxi Medical University, Nanning · Nanning Second People's Hospital, Nanning · Wuzhou Red Cross Hospital, Wuzhou
Registry updated 2026-10-30
NCT07901569
Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma
Research · Liu Zhuo
Peking University Third Hospital, Beijing
Registry updated 2026-10-28
NCT07293351
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Beijing · Beijing · Beijing · Changsha Shi · Guangzhou · Harbin · Nanjing · Shanghai Shi · Tianjin
Registry updated 2026-10-23
NCT06730672
An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
Trial Treatment · Phase 2 · Sun Yat-sen University
Sun Yat-sen University Cancer Center, Guangzhou · Henan Provincial People's Hospital, Zhengzhou
Registry updated 2026-10-22
NCT07888608
Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
Trial Treatment · Shao Pengfei
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing
Registry updated 2026-10-22
NCT07877194
A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
Trial Treatment · Phase 2 · Summit Therapeutics
Beijing
Registry updated 2026-10-16
NCT07672860
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
Trial Treatment · Phase 2 · Jinling Hospital, China
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Nanjing
Registry updated 2026-10-15
NCT07874542
Plasma DNA Methylation for Preoperative Classification of Renal Masses
Research · RenJi Hospital
RenJi Hospital, Shanghai
Registry updated 2026-10-15
NCT07875946
68Ga- and 18F-CAIX PET Imaging Study
Trial Treatment · Early phase 1 · Peking University First Hospital
Department of Nuclear Medicine, Peking University First Hospital, Beijing
Registry updated 2026-10-15
NCT07875959
18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
Trial Treatment · Peking University First Hospital
Peking University First Hospital, Beijing
Registry updated 2026-10-15
NCT07770802
Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)
Trial Treatment · Phase 1 · Hangzhou Huasai Biomedicine Co., Ltd.
Beijing Cancer Hospital, Beijing · Beijing GoBroad Hospital, Beijing
Registry updated 2026-10-14
NCT07833085
CAIX-targeted PET/CT in Solid Tumors
Trial Treatment · Zhongnan Hospital
Zhongnan Hospital of Wuhan University, Wuhan
Registry updated 2026-10-13
NCT07227415
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Trial Treatment · Phase 1/2 · Pfizer
Beijing Cancer Hospital, Beijing · Hunan Cancer Hospital, Changsha · Chongqing University Cancer Hospital, Chongqing · Qilu Hospital of Shandong University, Jinan · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · The First Affiliated Hospital of Ningbo University, Ningbo · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-10-08
NCT07865832
A Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma
Trial Treatment · Early phase 1 · Liangyou Gu
Chinese People's Liberation Army General Hospital, Beijing
Registry updated 2026-10-08
NCT07470840
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
Trial Treatment · Phase 2 · Fujian Cancer Hospital
Fujian Cancer Hospital, Fuzhou
Registry updated 2026-10-01
NCT07039474
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Research · Peking University First Hospital
Peking University First Hospital, Beijing
Registry updated 2026-09-28
NCT07704970
QLESP Block for Pain Control in Robotic Partial Nephrectomy
Trial Treatment · Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-09-25
NCT06916624
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Research · The Affiliated Hospital of Qingdao University
The Affiliated Hospital of Qingdao University, Qingdao
Registry updated 2026-09-17
NCT07623369
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Huahui Health
Shandong Tumour Hospital Dongyuan Unit, Jinan
Registry updated 2026-08-21
NCT06792552
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · NextCure, Inc.
The first medical center of PLA general hospital, Beijing · HunanCancer Hospital, Changsha · Sun Yat-sen University Cancer Center, Guangzhou · Cancer Hospital of Shandong First Medical University, Jinan · Affiliated Hospital of Jining Medical University, Jining · Fudan University Shanghai Cancer Center, Shanghai · Liaoning Cancer Hospital & Institute, Shenyang · The Fourth Hospital of Hebei Medical University (Heibei Tumor Hospital), Shijiazhuang
Registry updated 2026-08-17
NCT07239596
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
Trial Treatment · Phase 1/2 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Beijing Cancer Hospital, Beijing
Registry updated 2026-08-11
NCT07615348
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Trial Treatment · Phase 2 · Jinling Hospital, China
The First Affiliated Hospital of Nanjing Medical University, Nanjing · Nanjing First Hospital, Nanjing Medical University, Nanjing · Sir Run Run Hospital, Nanjing Medical University, Nanjing · Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing · Wuxi No.2 People's Hospital (Jiangnan University Medical Center), Wuxi
Registry updated 2026-08-11
NCT07743749
An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors
Research · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing
Registry updated 2026-08-04

All Kidney cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error